CannTrust Holdings Incorporated (TSX:TRST)(NYSE:CTST), a federally licensed provider of medical cannabis, has named Greg Guyatt as its new chief executive officer, it was reported on Thursday.
Guyatt is the firm's present chief financial officer and will replace interim CEO, Robert Marcovitch.
Guyatt joined CannTrust in February 2019 as chief financial officer and is a Chartered Professional Accountant. He earlier served as the CFO of GreenSpace Brands Inc and has around 25 years of experience leading finance teams from the consumer packaged goods, pharmaceutical, and private equity sectors.
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
Kibow Biotech receives AANP Corporation of the Year Award
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning